Abstract
The molecular basis of CNS myelin regeneration (remyelination) is poorly understood. We generated a comprehensive transcriptional profile of the separate stages of spontaneous remyelination that follow focal demyelination in the rat CNS and found that transcripts that encode the retinoid acid receptor RXR-γ were differentially expressed during remyelination. Cells of the oligodendrocyte lineage expressed RXR-γ in rat tissues that were undergoing remyelination and in active and remyelinated multiple sclerosis lesions. Knockdown of RXR-γ by RNA interference or RXR-specific antagonists severely inhibited oligodendrocyte differentiation in culture. In mice that lacked RXR-γ, adult oligodendrocyte precursor cells efficiently repopulated lesions after demyelination, but showed delayed differentiation into mature oligodendrocytes. Administration of the RXR agonist 9-cis-retinoic acid to demyelinated cerebellar slice cultures and to aged rats after demyelination caused an increase in remyelinated axons. Our results indicate that RXR-γ is a positive regulator of endogenous oligodendrocyte precursor cell differentiation and remyelination and might be a pharmacological target for regenerative therapy in the CNS.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Accession codes
References
Prineas, J.W. & Connell, F. Remyelination in multiple sclerosis. Ann. Neurol. 5, 22–31 (1979).
Patani, R., Balaratnam, M., Vora, A. & Reynolds, R. Remyelination can be extensive in multiple sclerosis despite a long disease course. Neuropathol. Appl. Neurobiol. 33, 277–287 (2007).
Raine, C.S. & Wu, E. Multiple sclerosis: remyelination in acute lesions. J. Neuropathol. Exp. Neurol. 52, 199–204 (1993).
Goldschmidt, T., Antel, J., König, F.B., Brück, W. & Kuhlmann, T. Remyelination capacity of the MS brain decreases with disease chronicity. Neurology 72, 1914–1921 (2009).
Franklin, R.J.M. Why does remyelination fail in multiple sclerosis? Nat. Rev. Neurosci. 3, 705–714 (2002).
Chang, A., Tourtellotte, W.W., Rudick, R. & Trapp, B.D. Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. N. Engl. J. Med. 346, 165–173 (2002).
Kuhlmann, T. et al. Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis. Brain 131, 1749–1758 (2008).
Wolswijk, G. Chronic stage multiple sclerosis lesions contain a relatively quiescent population of oligodendrocyte precursor cells. J. Neurosci. 18, 601–609 (1998).
Nave, K.A. & Trapp, B.D. Axon-glial signaling and the glial support of axon function. Annu. Rev. Neurosci. 31, 535–561 (2008).
Fancy, S.P.J. et al. Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNS. Genes Dev. 23, 1571–85 (2009).
Miller, R.H. & Mi, S. Dissecting demyelination. Nat Neurosci. 10, 1351–4 (2007).
Woodruff, R.H. & Franklin, R.J.M. Demyelination and remyelination of the caudal cerebellar peduncle of adult rats following stereotaxic injections of lysolecithin, ethidium bromide, and complement/anti-galactocerebroside: a comparative study. Glia 25, 216–228 (1999).
Germain, P. et al. International Union of Pharmacology. LXIII. Retinoid X receptors. Pharmacol. Rev. 58, 760–772 (2006).
Lefebvre, P., Benomar, Y. & Staels, B. Retinoid X receptors: common heterodimerization partners with distinct functions. Trends Endocrinol. Metab. 21, 676–683 (2010).
Franklin, R.J.M. & ffrench-Constant, C. Remyelination in the CNS: from biology to therapy. Nat. Rev. Neurosci. 9, 839–855 (2008).
Schrage, K., Koopmans, G., Joosten, E.A.J. & Mey, J. Macrophages and neurons are targets of retinoic acid signaling after spinal cord contusion injury. Eur. J. Neurosci. 23, 285–295 (2006).
Cahoy, J.D. et al. A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function. J. Neurosci. 28, 264–278 (2008).
Krezel, W. et al. RXR gamma null mice are apparently normal and compound RXR alpha+/−/RXR beta−/−/RXR gamma−/− mutant mice are viable. Proc. Natl. Acad. Sci. USA 93, 9010–9014 (1996).
Haugen, B.R. et al. Retinoid X receptor gamma-deficient mice have increased skeletal muscle lipoprotein lipase activity and less weight gain when fed a high-fat diet. Endocrinology 145, 3679–3685 (2004).
Brown, N.S. et al. Thyroid hormone resistance and increased metabolic rate in the RXR-gamma–deficient mouse. J. Clin. Invest. 106, 73–79 (2000).
Krzyżosiak, A. et al. Retinoid X receptor gamma control of affective behaviors involves dopaminergic signaling in mice. Neuron 66, 908–920 (2010).
Takahashi, B. et al. Novel retinoid X receptor antagonists: specific inhibition of retinoid synergism in RXR-RAR heterodimer actions. J. Med. Chem. 45, 3327–3330 (2002).
Heyman, R.A. et al. 9-cis retinoic acid is a high affinity ligand for the retinoid X receptor. Cell 68, 397–406 (1992).
Pombo, P.M., Barettino, D., Ibarrola, N., Vega, S. & Rodríguez-Peña, A. Stimulation of the myelin basic protein gene expression by 9-cis-retinoic acid and thyroid hormone: activation in the context of its native promoter. Brain Res. Mol. Brain Res. 64, 92–100 (1999).
Kagechika, H. & Shudo, K. Synthetic retinoids: recent developments concerning structure and clinical utility. J. Med. Chem. 48, 5875–5883 (2005).
Nishimaki-Mogami, T. et al. The RXR agonists PA024 and HX630 have different abilities to activate LXR/RXR and to induce ABCA1 expression in macrophage cell lines. Biochem. Pharmacol. 76, 1006–1013 (2008).
Birgbauer, E., Rao, T.S. & Webb, M. Lysolecithin induces demyelination in vitro in a cerebellar slice culture system. J. Neurosci. Res. 78, 157–166 (2004).
Klemann, C. et al. Synthetic retinoid AM80 inhibits Th17 cells and ameliorates experimental autoimmune encephalomyelitis. Am. J. Pathol. 174, 2234–2245 (2009).
Sim, F.J., Zhao, C., Penderis, J. & Franklin, R.J.M. The age-related decrease in CNS remyelination efficiency is attributable to an impairment of both oligodendrocyte progenitor recruitment and differentiation. J. Neurosci. 22, 2451–2459 (2002).
Moreno, S., Farioli-Vecchioli, S. & Cerù, M.P. Immunolocalization of peroxisome proliferator-activated receptors and retinoid X receptors in the adult rat CNS. Neuroscience 123, 131–145 (2004).
Sim, F.J. et al. Complementary patterns of gene expression by human oligodendrocyte progenitors and their environment predict determinants of progenitor maintenance and differentiation. Ann. Neurol. 59, 763–779 (2006).
Altucci, L., Leibowitz, M.D., Ogilvie, K.M., de Lera, A.R. & Gronemeyer, H. RAR and RXR modulation in cancer and metabolic disease. Nat. Rev. Drug Discov. 6, 793–810 (2007).
Trousson, A. et al. 25-hydroxycholesterol provokes oligodendrocyte cell line apoptosis and stimulates the secreted phospholipase A2 type IIA via LXR beta and PXR. J. Neurochem. 109, 945–958 (2009).
Granneman, J., Skoff, R. & Yang, X. Member of the peroxisome proliferator-activated receptor family of transcription factors is differentially expressed by oligodendrocytes. J. Neurosci. Res. 51, 563–573 (1998).
Almad, A. & McTigue, D.M. Chronic expression of PPAR-delta by oligodendrocyte lineage cells in the injured rat spinal cord. J. Comp. Neurol. 518, 785–799 (2010).
Diab, A. et al. Ligands for the peroxisome proliferator-activated receptor-gamma and the retinoid X receptor exert additive anti-inflammatory effects on experimental autoimmune encephalomyelitis. J. Neuroimmunol. 148, 116–126 (2004).
Du, P., Kibbe, W.A. & Lin, S.M. lumi: a pipeline for processing Illumina microarray. Bioinformatics 24, 1547–1548 (2008).
Georgiades, P. & Brickell, P.M. Differential expression of the rat retinoid X receptor gamma gene during skeletal muscle differentiation suggests a role in myogenesis. Dev. Dyn. 210, 227–235 (1997).
McCarthy, K.D. & de Vellis, J. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J. Cell Biol. 85, 890–902 (1980).
Laursen, L.S., Chan, C.W. & ffrench-Constant, C. An integrin-contactin complex regulates CNS myelination by differential Fyn phosphorylation. J. Neurosci. 29, 9174–9185 (2009).
Acknowledgements
We thank D. Seilhean (Service d'Anatomopathologie Neurologique, G-H Pitié-Salpêtrière, Paris) for classification of multiple sclerosis lesions, the French Brain Bank GIE NeuroCEB (Hôpital Pitié-Salpêtrière, Paris, France) and the United Kingdom Multiple Sclerosis Society Brain Bank (R. Reynolds, Imperial College, London) for multiple sclerosis tissue. All tissues were collected with the approval of the French and London Multicentre Research Ethics committees. Animal procedures were performed under a UK Home Office Project License. This work was supported by grants from the United Kingdom Multiple Sclerosis Society (R.J.M.F., C.ff.-C.), the Wellcome Trust (C.ff.-C.), the French Multiple Sclerosis foundation ARSEP (B.N.O.), the Biotechnology and Biological Sciences Research Council of the United Kingdom (C.ff.-C., J.B.), National Multiple Sclerosis Society (C.ff.-C., R.J.M.F., A.B.-V.E., B.N.O.), AP-HP Hôpital Pitié-Salpêtrière, Service d'Anatomopathologie Neurologique (B.N.O.) et des Maladies du Système Nerveux (A.B.-V.E.). A.W. holds a Wellcome Trust Intermediate Fellowship. A.A.J. holds a Fellowship from Multiple Sclerosis Society of Canada.
Author information
Authors and Affiliations
Contributions
J.K.H. performed in vivo experiments and laser capture microdissections. A.A.J. performed in vitro experiments. C.Z. contributed to in vivo experiments. A.W. performed ex vivo experiments. B.N.O., C.K. and A.B.-V.E. performed multiple sclerosis tissue analysis. H.K. generated RXR antagonists and agonists. W.K. and P.C. generated the RXR-γ mouse mutants. J.B. and J.K.H. performed bioinformatics. C.ff.-C. and R.J.M.F. equally oversaw the project.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Text and Figures
Supplementary Figures 1–7 and Supplementary Tables 5, 7 (PDF 1078 kb)
Supplementary Table 1
Total genes differentially expressed between 5, 14 and 28 days post CCP demyelination. (XLS 5299 kb)
Supplementary Table 2
Gene list used for IPA analysis. (XLS 96 kb)
Supplementary Table 3
Active signaling networks found between 5 and 14 dpl. (XLS 66 kb)
Supplementary Table 4
Total genes differentially expressed between 5 and 14 dpl (P < 0.05) used for volcano plot. (XLS 714 kb)
Supplementary Table 6
IPA identified RXR associated pathways from the remyelination transcriptome. (XLS 199 kb)
Rights and permissions
About this article
Cite this article
Huang, J., Jarjour, A., Nait Oumesmar, B. et al. Retinoid X receptor gamma signaling accelerates CNS remyelination. Nat Neurosci 14, 45–53 (2011). https://doi.org/10.1038/nn.2702
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nn.2702
This article is cited by
-
Human nutritional relevance and suggested nutritional guidelines for vitamin A5/X and provitamin A5/X
Nutrition & Metabolism (2023)
-
Oligodendrocyte progenitor cells in Alzheimer’s disease: from physiology to pathology
Translational Neurodegeneration (2023)
-
Inflammation in multiple sclerosis: consequences for remyelination and disease progression
Nature Reviews Neurology (2023)
-
Multiple Sclerosis Pathogenesis and Updates in Targeted Therapeutic Approaches
Current Allergy and Asthma Reports (2023)
-
Microbial pathogens induce neurodegeneration in Alzheimer’s disease mice: protection by microglial regulation
Journal of Neuroinflammation (2022)